2026 Estimated Acquired IPR&D And Development Milestone Charges for Q3 2026

Eli Lilly and Company published this content on October 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 08, 2026 at 07:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]